🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT06988839
Recruiting Not applicable

Effect Of Microneedling With Coronally Advanced Flap For Management of RT1 Gingival Recession In Thin Gingival Phenotype

NCT06988839 · tracked via the Priya Life Science India tracker
Sponsor
Postgraduate Institute of Dental Sciences Rohtak
Phase
Not applicable
Started
2025-06-26
Last updated
2026-06-12

Condition(s) studied

Gingival Recession

Investigational drug(s) / intervention(s)

Microneedling followed by coronally advanced flapCoronally advanced flap with connective tissue graft

Microneedling followed by coronally advanced flap: Microneedling will be performed using a 30 gauge lancet needles, inserted until hard tissue is felt. It will be performed in 4 sessions at 10 day intervals, followed by coronally advanced flap procedure, 2 months post microneedling.

Coronally advanced flap with connective tissue graft: Coronally advanced flap operation will be performed with connective tissue graft harvested from palate after phase 1 therapy.

Study summary

The goal of this clinical trial is to explore the effect of microneedling to increase the gingival tissue thickness which could improve the outcome of root coverage in coronally advanced flap procedure in thin gingival phenotype. The main question it aims to answer is that :

Does the use of microneedling procedure followed by coronally advanced flap has similar outcomes of root coverage in recession type 1 (RT1) gingival recession i.e. buccal gingival recessions without interdental clinical attachment loss in thin gingival phenotype as compared to coronally advanced flaps with connective tissue graft.

Systemically healthy patients having isolated upper RT1 gingival recession will be assigned into two groups. Microneedling will be performed in one group (4 sessions each at a 10 days interval) followed by coronally advanced flap operation (at an interval of 2 months) and coronally advanced flap with connective tissue graft will be performed in the other group. Follow-up will be done at 1 month, 3 months and 6 months for evaluation of primary and secondary outcomes.

Eligibility

Sex
ALL
Min age
20 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * Presence of isolated RT1 buccal maxillary gingival recessions in esthetic zone with thin gingival phenotype (Gingival thickness≤1mm) associated with esthetic complaints and/or dental sensitivity and otherwise systemically healthy. * Gingival Recession ≥2mm , Keratinized tissue width≥2mm and clinically identifiable cementoenamel junction * Age 20years-50 years * Patient demonstrating compliance for maintaining good oral hygiene after Phase 1 therapy Plaque index (PI) \<1, Gingival Index (GI) \<1 * Providing a written and verbal informed consent. Exclusion Criteria: * Patient with systemic disease that can influence the outcome of therapy. * Pregnant females or on oral contraceptive pills or hormone replacement therapy. * Smokers and patients undergoing orthodontic therapy * Physically and mentally impaired patients. * Non vital, malpositioned tooth * Presence of cervical abrasions or restorations in the area * Previous history of periodontal surgery on the involved sites.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Periodontology, Post Graduate Institute of Dental Sciences Rohtak Haryana Recruiting

More Postgraduate Institute of Dental Sciences Rohtak trials in India

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06988839 on ClinicalTrials.gov ↗ ← All trials in India